NCT01091207
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Clinical trial condition
Gastrointestinal Stromal Tumors
Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.
93 public trials
21 recruiting studies
Gastrointestinal Stromal Tumors trial results
NCT00564265
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Hospital De La Serena La Serena, Coquimbo Region, Chile
Completed
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
NCT00500188
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT01114087
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +18 more
- Locations
-
- Department of Biology of reproduction (TENON Hospital-APHP) Paris, France
NCT00276302
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +8 more
- Locations
-
- Premiere Oncology Scottsdale, Arizona, United States
- Premiere Oncology Santa Monica, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Michigan Hosptials Ann Arbor, Michigan, United States
NCT00877045
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Florida Cancer Specialists Fort Myers, Florida, United States
- Georgia Cancer Specialists Atlanta, Georgia, United States
- Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States
- Tennessee Oncology, PLLC Nashville, Tennessee, United States
NCT00457743
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Kashiwa, Chiba, Japan
- Pfizer Investigational Site Sapporo, Hokkaido, Japan
- Pfizer Investigational Site Suita, Osaka, Japan
- Pfizer Investigational Site Chuo-ku, Tokyo, Japan
NCT00137449
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Pfizer Investigational Site Boston, Massachusetts, United States
- Pfizer Investigational Site Lyon, France
- Pfizer Investigational Site Villejuif, France
- Pfizer Investigational Site Milan, Italy
Active, Not Recruiting
Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
NCT06087263
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
NCT03673501
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- University of California San Diego Medical Center La Jolla, California, United States
- UCLA Hematology Oncology Center - Main Site Los Angeles, California, United States
- Stanford Medicine Stanford, California, United States